Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1989-08-24
1991-02-12
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514114, 514128, 514130, 549563, 556405, 558169, 558177, 560 9, 560 11, 560 12, 560 13, 560 14, 560 45, 560 59, 562 11, 562 23, A61K 3166, C07D 930, C07D 932
Patent
active
049924290
ABSTRACT:
Disclosed are novel substituted cyclohexenyl phosphinylhydroxybutyrates as 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors useful as antihypercholesterolemic agents represented by the formula: ##STR1## and pharmaceutically acceptable salts thereof.
REFERENCES:
patent: 4268507 (1981-05-01), Nguyen Mong
patent: 4282155 (1981-08-01), Smith et al.
patent: 4567289 (1986-01-01), Willard et al.
patent: 4611067 (1986-09-01), Volante et al.
patent: 4668699 (1987-05-01), Hoffman et al.
patent: 4681893 (1987-07-01), Roth
patent: 4904646 (1990-02-01), Karanewsky et al.
Core et al., J. Med. Chem., 12, pp. 334-336 (1969).
Neuenschwander Kent W.
Regan John R.
Ullrich John W.
Balogh Imre (Jim)
Bernhardt Emily
Nicholson James A.
Rhone-Poulenc Rorer Pharmaceuticals Inc.
Shah Mukund J.
LandOfFree
Novel HMG-COA reductase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel HMG-COA reductase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel HMG-COA reductase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-20673